Pfizer And Biontech's Vaccine Has More Than 90 Percent Effect Against Covid-19!

Pfizer And Biontech's Vaccine Has More Than 90 Percent Effect Against Covid-19! Pfizer And Biontech's Vaccine Has More Than 90 Percent Effect Against Covid-19! Pfizer announced that the experimental Covid-19 vaccine they found was more than 90 percent effective. New York-based American pharmaceutical company Pfizer and its German partner BioNTech SE (NASDAQ: BNTX) were the first drug manufacturers to publish successful data on the coronavirus vaccine in a large-scale clinical trial. In the statement made by the company officials; It was stated that the vaccine found was a great victory against the Covid-19 epidemic, which killed more than a million people and disrupted daily life with its damage to the world economy. The companies said they have not found a serious safety concern in the effects of the vaccine they have produced so far, and they expect to get permission from the United States to start use this month. If the necessary permissions are obtained, the vaccine will be used, but the number of doses will be limited at the first stage. There are many more questions to be answered, including how long the vaccine will provide protection, according to officials. However, the hope remains that other Covid-19 vaccines under development will also be effective. Commenting on the subject, Albert Bourla, Pfizer President and Chief Executive Officer, said: "Today is a great day for science and humanity. In our vaccine development program, infection rates are breaking new records, hospitals approaching overcapacity and trying to get back up. “Together with the economies, we are reaching this at a critical time when the world needs it most.” Expecting to obtain a broad US authorization covering emergency use of the vaccine for people aged 16 to 85, Pfizer will collect two months of safety data, which will be collected from about half of the 44,000 participants later this month.   Shares of Companies Increased MSCI, the indicator of the world stock market markets, reached a record level after the announcement. Pfizer shares rose 6 percent in New York, while BioNTech's US shares jumped 18 percent. Shares of other Covid-19 vaccine developers, who are in the final stage of testing, also reacted to this news; AstraZeneca (NYSE: AZN) rose 0.5 percent in London, while Johnson & Johnson gained 2.6 percent in pre-market trading. Moderna (NASDAQ: MRNA), on the other hand, dropped 1.8 percent before the US session began. Bill Gruber, one of Pfizer's top vaccine scientists, said in an interview: “I am almost ecstatic. This is a great day for public health and the potential to remove us all from the conditions we are now in.”   1.3 Billion Doses Pfizer and BioNTech has signed a partnership for a $1.95 billion contract with the US government to provide 100 million doses of vaccine starting this year. There were also supply agreements with the European Union, UK, Canada and Japan. That's how companies began to produce the vaccine to save time, not knowing whether it would be effective. For now, they plan to produce 50 million vaccines, or enough doses to protect 25 million people this year. Pfizer announced that they will produce 1.3 billion doses of vaccine in 2021. After the news of the vaccine, world indices started to rise. In this context; oil gained 8 percent, gold lost 2 percent. Brent rose to the $ 43 level in the last hour, while the ounce fell to $ 1,920. BIST 100 increased its earnings by 3 percent and reached 1,230 points. USD / TRY traded at 8.03. Gram of gold increased its daily loss to 7.5 percent with the decrease in ounce and dollar exchange rates and its price decreased to 495 TL.